Medtronic (NYSE:MDT) today announced the enrollment of the first patient in its ENDURANCE post-approval study of its Altaviva ...
European approval introduces the world's only closed-loop DBS system with real-time, self-adjusting brain stimulation for people with Parkinson's disease For 30 years, people with Parkinson's disease ...
Medtronic has received FDA clearance for a mobile app that allows patients to remotely forward data from their pacemakers with their physicians. The app is paired with a device, the MyCareLink Smart ...
DUBLIN, March 24, 2022 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the first patient implants in the TITAN 2 pivotal study that will evaluate ...
Medtronic and Philips have re-upped their long-running partnership focused on bundling vital sign sensors together with patient monitoring equipment. The two medtechs said the collaboration extends ...
On Monday, the FDA approved Medtronic plc’s (NYSE:MDT) BrainSense Adaptive deep brain stimulation (aDBS) and BrainSense Electrode Identifier (EI) for patients with Parkinson’s disease. Deep brain ...
Our acute care and monitoring solutions address unmet clinical needs, reduce the cost of care, 6-9 and streamline workflows, 10-12 all while keeping the patient at the center of everything we do. Our ...
More than a year after laying out a plan to divest its patient monitoring and respiratory interventions businesses—sparking months of speculation over potential buyers—Medtronic is reworking the ...
Medical leaders Medtronic and Abbott are collaborating on diabetes care in a new partnership that will combine technologies to expand options for patients. Medtronic is known for insulin pumps with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results